This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the FDA clearance of Boston Scientific's Asurys Fluid Management System, Designed to Provide Irrigation and Distention During Endoscopic Urologic Procedures

Ticker(s): BSX

Who's the expert?

Institution: Mayo Clinic 

  • Urologic oncologist, with specialty interest in the surgical management of prostate, bladder, and kidney cancer
  • Clinical focus includes: Robotic radical prostatectomy for prostate cancer, open and robotic radical cystectomy with urinary diversion for bladder cancer, open, laparoscopic, and robotic partial and radical nephrectomy for kidney cancer

  • Authors expert content and publishes in high-impact scientific journals

  • Manages 380 patients per month for urologic procedures

Interview Goal
This conversation will focus on the treatment landscape and potential use of Asurys Fluid Management System for patients undergoing urologic procedures.

Are You Interested In These Questions?

Slingshot Insights Explained
3Days Left to Join Project

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.